Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma. 2020

Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.

The extracellular matrix (ECM) plays an important role in the regulation of the tissue microenvironment and in the maintenance of cellular homeostasis. Several proteins with a proteolytic activity toward several ECM components are involved in the regulation and remodeling of the ECM. Among these, Matrix Metalloproteinases (MMPs) are a class of peptidase able to remodel the ECM by favoring the tumor invasive processes. Of these peptidases, MMP-9 is the most involved in the development of cancer, including that of melanoma. Dysregulations of the MAPKs and PI3K/Akt signaling pathways can lead to an aberrant overexpression of MMP-9. Even ncRNAs are implicated in the aberrant production of MMP-9 protein, as well as other proteins responsible for the activation or inhibition of MMP-9, such as Osteopontin and Tissue Inhibitors of Metalloproteinases. Currently, there are different therapeutic approaches for melanoma, including targeted therapies and immunotherapies. However, no biomarkers are available for the prediction of the therapeutic response. In this context, several studies have tried to understand the diagnostic, prognostic and therapeutic potential of MMP-9 in melanoma patients by performing clinical trials with synthetic MMPs inhibitors. Therefore, MMP-9 may be considered a promising molecule for the management of melanoma patients due to its role as a biomarker and therapeutic target.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics
D061965 Matrix Metalloproteinase Inhibitors Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. Collagenase Inhibitor,Gelatinase Inhibitor,MMP Inhibitor,Matrix Metalloproteinase Inhibitor,Collagenase Inhibitors,Gelatinase Inhibitors,MMP Inhibitors,Stromelysin Inhibitors,Inhibitor, Collagenase,Inhibitor, Gelatinase,Inhibitor, MMP,Inhibitor, Matrix Metalloproteinase,Inhibitors, Collagenase,Inhibitors, Gelatinase,Inhibitors, MMP,Inhibitors, Matrix Metalloproteinase,Inhibitors, Stromelysin,Metalloproteinase Inhibitor, Matrix,Metalloproteinase Inhibitors, Matrix
D020782 Matrix Metalloproteinases A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components. MMP,MMPs,Matrix Metalloproteinase,Metalloproteinase, Matrix,Metalloproteinases, Matrix

Related Publications

Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
December 2020, International journal of molecular sciences,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
June 2014, Cancers,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
January 2001, Methods in molecular medicine,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
October 1995, Acta orthopaedica Scandinavica. Supplementum,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
January 1999, Anticancer research,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
August 1992, American journal of respiratory cell and molecular biology,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
January 2012, Postepy biochemii,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
October 2000, The British journal of ophthalmology,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
April 1990, Trends in genetics : TIG,
Salvatore Napoli, and Chiara Scuderi, and Giuseppe Gattuso, and Virginia Di Bella, and Saverio Candido, and Maria Sofia Basile, and Massimo Libra, and Luca Falzone
June 2023, International journal of molecular sciences,
Copied contents to your clipboard!